Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The net proceeds of the financing round will be used to to discover precision medicines for metabolic syndrome-related conditions and to demonstrate proof-of-concept for MultiOmic’s MOHSAIC® platform in diabetic kidney disease.
Lead Product(s): Undisclosed
Therapeutic Area: Nephrology Product Name: Undisclosed
Highest Development Status: ApprovedProduct Type: Large molecule
Partner/Sponsor/Collaborator: Hoxton Ventures
Deal Size: $8.6 million Upfront Cash: Undisclosed
Deal Type: Financing May 03, 2023